Pazopanib for metastatic soft | 合法藥品大搜索

由 ATJ Lee 著作 · 2019 · 被引用 27 次 — Pazopanib is the first and only tyrosine kinase inhibitor currently approved for the treatment of multiple histological subtypes of soft tissue ... Read More

EFFICACY OF PAZOPANIB IN SARCOMA PATIENTS · 由 BA Wilky 著作 · 2013 · 被引用 23 次 — Pazopanib has been tested in sarcoma patients in a phase II and phase III study, and ... Read More

Pazopanib expLorEd in sofT-Tissue sarcoma – a phasE III study · 由 LD Cranmer 著作 · 2016 · 被引用 24 次 — Table 1. Clinical studies of pazopanib enrolling soft tissue sarcoma patients ... Read More

由 WTA van der Graaf 著作 · 2012 · 被引用 1533 次 — Background: Pazopanib, a multitargeted tyrosine kinase inhibitor, has single-​agent activity in patients with advanced non-adipocytic soft-tissue ... Read More

由 HJ Kim 著作 · 2018 · 被引用 12 次 — Pazopanib monotherapy in the treatment of pretreated, metastatic uterine sarcoma: a single-center retrospective study. J Gynecol Oncol. 2018 Jan;29(1):e3​. doi: ... Read More

由 S Sleijfer 著作 · 2009 · 被引用 650 次 — PURPOSE Given the importance of angiogenesis in soft tissue sarcoma (STS), pazopanib, an oral angiogenesis inhibitor that targets vascular endothelial ... Read More

由 S Koca 著作 · 2021 · 被引用 1 次 — Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study. J Oncol Pharm Pract. 2021 Apr;27(3):541-546. doi: 10.1177/1078155220924075 ... Read More

2020年9月9日 — For children and adults with advanced soft tissue sarcoma, adding pazopanib (​Votrient) to chemotherapy and radiation may be a new treatment ... Read More

由 WTA van der Graaf 著作 · 2012 · 被引用 1533 次 — Pazopanib, a multitargeted tyrosine kinase inhibitor, has single-agent activity in patients with advanced non-adipocytic soft-tissue sarcoma. Read More

2020年12月23日 — Importance Pazopanib and gemcitabine have shown good tolerability, albeit modest single-agent activity in pretreated soft tissue sarcoma. A ... Read More